Abstract
The in vivo activity of olamufloxacin (HSR-903), a new fluoroquinolone, was evaluated and compared with ciprofloxacin, sparfloxacin and levofloxacin. Olamufloxacin was active against systemic infection in mice inoculated with both Gram-positive and -negative bacteria. Olamufloxacin had equal efficacy for experimental urinary tract infections in mice caused by Pseudomonas aeruginosa.
Cite
CITATION STYLE
Yoshizumi, S., Takahashi, Y., Murata, M., Domon, H., Furuya, N., Ishii, Y., … Yamaguchi, K. (2001). The in vivo activity of olamufloxacin (HSR-903) in systemic and urinary tract infections in mice. Journal of Antimicrobial Chemotherapy, 48(1), 137–140. https://doi.org/10.1093/jac/48.1.137
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
